FDA Releases Draft Guidance With Updated Recommendations for Blood Donation Deferrals for At-Risk Groups
The FDA’s Center for Biologics Evaluation and Research released draft guidance on evaluating donor eligibility by risk-based questions to reduce the risk of HIV transmission by blood and blood products.
